October 9, 2025
5 min read
October 9, 2025
5 min read
Raising startup capital is rarely straightforward. The first challenge is convincing investors. The second, less glamorous challenge is deciding how to structure the deal. But before you even incorporate your startup, there’s an equally important decision — timing your incorporation can affect how and when you’re able to raise formally.
Founders often hear the terms convertible note, SAFE, and priced equity thrown around in early conversations but are rarely given a clear framework to choose between them. The reality is that the instrument you use to raise has long-term consequences. It affects how much equity you and your team keep, how attractive your company looks to future investors, and how smoothly your fundraising process unfolds.
Many founders only realize the impact of their choice when they’re already negotiating a Series A or trying to clean up a messy cap table.
This guide is designed to be the single most comprehensive resource on the topic. It breaks down what each instrument is, how they compare, when to use them, and the mistakes to avoid.
Before choosing, it’s essential to understand the fundamentals. Each option comes with different mechanics, risks, and implications.
A convertible note is debt that converts into equity at a later financing round. It’s called a “note” because it starts life as a loan from the investor to the company. The loan doesn’t stay debt forever; it converts to equity once you raise a priced round.
Core features:
Convertible notes were the standard pre-seed/seed fundraising tool before SAFEs. They remain common outside Silicon Valley, where some investors still prefer the protections that come with debt.
The SAFE was introduced by Y Combinator in 2013 to simplify early-stage investing. Unlike a note, a SAFE is not debt. It carries no interest rate or maturity date. It simply promises future equity at the next priced round, usually with a discount or valuation cap.
Core features:
SAFEs quickly became the default in Silicon Valley, especially for pre-seed and early seed rounds, because they remove the burden of debt obligations while maintaining simplicity.
A priced round is the traditional form of raising venture capital. The company and investors agree on a valuation today, issue shares immediately, and update the cap table. This requires full legal documentation and often comes with investor rights and governance structures.
Core features:
Priced rounds are unavoidable at later stages. They become common at Series A and sometimes at late-seed when institutional investors enter the picture.
Here’s a summary comparison across the dimensions that matter most to founders:
Bring up structure in initial conversations. Some investors will only invest through their preferred instrument. Don’t wait until closing to discover this.
Use spreadsheets to model how much equity you and your co-founders will own under different scenarios. SAFEs and notes push dilution into the future, making it easy to underestimate.
Pro Tip:
Always model conversion at both the cap and the discount. This helps you anticipate worst-case dilution scenarios if your priced round valuation is lower than expected.
Even if you raise with SAFEs or notes, keep records updated and plan for conversion in the next priced round. Cap table chaos is one of the biggest blockers to Series A.
Founders sometimes issue multiple SAFEs across different valuations and terms. When they all convert, the cap table becomes unpredictable and unattractive to future investors.
Solution: Limit the number of different instruments, and consolidate before raising a priced round.
A SAFE with a $5M cap can look great when raising, but if your Series A is at $15M, those early investors convert at $5M and take a much larger chunk than you modeled.
Solution: Carefully negotiate caps, and always model both best- and worst-case outcomes.
If you set a valuation too early, you risk mispricing the company. A high valuation without traction makes the next round difficult. A low valuation locks in unnecessary dilution.
Solution: Delay priced rounds until you have traction and data to justify valuation.
Because SAFEs don’t carry maturity or interest, some founders treat them casually. But every SAFE represents dilution waiting to happen.
Solution: Track SAFEs diligently. Use cap table software to simulate future ownership.
Some SAFEs and notes include MFN clauses, meaning if you later issue better terms to new investors, earlier ones can opt in. Founders often overlook this.
Q: Can I raise both SAFEs and notes at the same time?
Yes, but it complicates conversion and cap table management. Pick one instrument per round if possible.
Q: When do SAFEs convert into equity?
At the next priced round that meets the definition of an equity financing, usually a seed or Series A.
Q: Do convertible notes always need to be repaid?
Not if they convert. But if no qualifying round occurs before maturity, investors could demand repayment.
Q: Do priced rounds always require a lead investor?
Typically yes. A lead sets terms, valuation, and often takes a board seat.
Choosing between a convertible note, a SAFE, and a priced equity round is one of the most strategic early financing decisions a founder will make. It influences dilution, investor dynamics, and the path to future rounds.
Key takeaways:
Founders should model outcomes, understand implications, and avoid kicking problems into the future. A clean, predictable cap table is one of the strongest signals to institutional investors.
For more hands-on tools, sign up for our newsletter and get our free Startup Fundraising Checklist to help you prepare your round with confidence.
September 25, 2025
12 min read